{"publication_id":"456e9e42-fa00-477e-afb6-ba411ff85156","content_hash":"sha256:dfa0917a901e69e952606cf985cf65f9a99bd889a128de99bf5aa90f22c8b316","nodes":[{"id":"456e9e42-fa00-477e-afb6-ba411ff85156","type":"publication","title":"Bounded Gestational diabetes signal: HbA1c (-0.36%; -0.65 to -0.07)"},{"id":"claim_1","type":"claim","text":"The cited A/B receipts support a specific working claim: HbA1c (-0.36%; -0.65 to -0.07); Probiotic supplementation was not effective in decreasing FBG (Mean Difference = -0.13; 95% CI -0.32, 0.06, p = 0.18). The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis."},{"id":"claim_2","type":"claim","text":"Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication."},{"id":"claim_3","type":"claim","text":"The most publishable angle here is not which intervention works, but why certain interventions achieve hard clinical endpoints (macrosomia, C-section) with only marginal glycemic improvement—and why others mechanistically succeed (probiotic HOMA-IR reduction) yet fail at every clinical glucose threshold. A second underexplored angle is the disproportionate respiratory distress syndrome risk (RR 3.2) in *mild* GDM, which exceeds the effect on macrosomia and points to glycemic-independent fetal pulmonary programming."},{"id":"claim_4","type":"claim","text":"Real tension: Probiotic supplementation significantly reduces HOMA-IR (-0.69, p=0.01) yet produces null effects on fasting blood glucose (-0.13, p=0.18) and LDL cholesterol (-0.16, p=0.67) in the same GDM population [3 vs 8 vs 2] — the insulin sensitivity gain does not translate to glycemic or lipid endpoints"},{"id":"claim_5","type":"claim","text":"Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?"},{"id":"claim_6","type":"claim","text":"`fact_id=73726` (`A_core`) — Lifestyle intervention versus usual care probably reduces large‐for‐gestational age (risk ratio (RR) 0.60, 95% confidence interval (CI) 0.50 to 0.71; 6 RCTs, N = 2994; GRADE moderate‐quality). doi=10.1002/14651858.cd012327.pub2"},{"id":"source_1","type":"source","study":"Digital health interventions for gestational diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials","year":2022,"doi":"10.1371/journal.pdig.0000015","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_2","type":"source","study":"Effect of Probiotics on Metabolic Outcomes in Pregnant Women with Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":2017,"doi":"10.3390/nu9050461","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_3","type":"source","study":"Mild Gestational Diabetes and Adverse Pregnancy Outcome: A Systemic Review and Meta-Analysis","year":2021,"doi":"10.3389/fmed.2021.699412","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_4","type":"source","study":"Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews","year":2018,"doi":"10.1002/14651858.cd012327.pub2","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_5","type":"source","study":"Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management","year":2025,"doi":"10.3390/ijms26052320","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"primary"}],"edges":[{"from":"456e9e42-fa00-477e-afb6-ba411ff85156","to":"claim_1","type":"contains_claim"},{"from":"456e9e42-fa00-477e-afb6-ba411ff85156","to":"claim_2","type":"contains_claim"},{"from":"456e9e42-fa00-477e-afb6-ba411ff85156","to":"claim_3","type":"contains_claim"},{"from":"456e9e42-fa00-477e-afb6-ba411ff85156","to":"claim_4","type":"contains_claim"},{"from":"456e9e42-fa00-477e-afb6-ba411ff85156","to":"claim_5","type":"contains_claim"},{"from":"456e9e42-fa00-477e-afb6-ba411ff85156","to":"claim_6","type":"contains_claim"}],"screening":{"identified":5,"screened":5,"excluded":0,"included":5,"included_or_retained":5,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"5 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]}}